Abstract Background Radiation-induced heart disease (RIHD) may develop months to years following radiation therapy for cancers near the heart such as lung or breast cancer. Several
Abstract Background Assessing the biodistribution and absorbed dose of ¹³¹I is crucial for optimisation of radionuclide therapy, as well as for improving risk assessment following
Single-nucleus transcriptomics study mapping gene expression and regulatory networks in obese mice; mechanistic and exploratory, without clinical outcomes or direct human validation of therapeutic efficacy.